Polar Capital Holdings’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
DM
SCM
HA
FBIL
Polar Capital Holdings's LEGN Position: Q1 2026 in Review
Polar Capital Holdings sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 52,893 shares — an estimated $1.15M sold.
Polar Capital Holdings first reported a position in LEGN in Q1 2022 and held it in 16 quarters. The position peaked at $129M in Q2 2023. 190 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.
- Polar Capital Holdings reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
- Polar Capital Holdings sold 52,893 Legend Biotech shares in Q1 2026, an estimated $1.15M.
- Polar Capital Holdings first reported a position in Legend Biotech in Q1 2022 and held it in 16 quarters.
- Polar Capital Holdings's Legend Biotech position peaked at $129M in Q2 2023.
- 190 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.
Based on Polar Capital Holdings's 13F filing for Q1 2026, filed 15 May 2026.